Abstract
Understanding the mechanisms of pain is important for any clinician since chronic pain is a global problem that transcends all medical specialties. By understanding pain at a cellular level, clinicians can better apply multimodal pain therapies for their patients that address the four steps of pain signaling and processing: transduction, transmission, modulation, and perception. The purpose of this chapter is to explore each of these avenues along the pain pathway and examine some of the therapies currently being employed to treat pain at these levels. The chapter is divided into four sections, which are the four steps of the pain pathway. Within transduction, nociceptors and the process by which they detect noxious stimuli are discussed. Transmission focuses on the types of nerve fibers involved in pain signaling and the differences among them. The section on modulation investigates peripheral, spinal, and supraspinal mechanisms by which “pain” transmission is modified, including peripheral and central sensitization mechanisms. Finally, perception describes the key centers of the brain responsible for pain processing and examines the influence of context and emotions.
References
Cohen SP, Mao J. Neuropathic pain: mechanisms and their clinical implications. BMJ. 2014;348:f7656.
Walsh DA, McWilliams DF. Pain in rheumatoid arthritis. Curr Pain Headache Rep. 2012;16:509–17.
Woolf CJ, Max MB. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology. 2001;95:241–9.
Bonica JJ. Bonica’s management of pain. Philadelphia: Lippincott Williams & Wilkins; 2010.
Messlinger K. Functional morphology of nociceptive and other fine sensory endings in different tissues. Prog Brain Res. 1996;113:273–98.
Devor M, Keller CH, Deerinck RJ, et al. Na+ channel accumulation on axolemma of afferent endings in nerve end neuromas in Apteronotus. Neurosci Lett. 1989;102:149–54.
Lindia JA, Kohler MG, Martin WJ, et al. Relationship between sodium channel Nav1.3 expression and neuropathic pain behavior in rats. Pain. 2005;117:145–53.
Lou ZD, Calcutta NA, Higuera ES, et al. Injury type-specific calcium channel α2δ-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther. 2002;303:1199–205.
Suman-Chauhan N, Webdale L, Hill DR, et al. Characterization of [3H]gabapentin binding to a novel site in rate brain: homogenate binding studies. Eur J Pharmacol. 1993;244:293–301.
Miller KE, Hoffman EM, Sutherham M, et al. Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanism. Pharmacol Ther. 2011;130:283–309.
Harris RT, Napadow V, Huggins JP, et al. Pregabalin rectifies aberrant brain chemistry connectivity, and functional response in chronic pain patients. Anesthesiology. 2013;119:1453–64.
Kohno R, Ji RR, Ito N, et al. Peripheral axonal injury results in reduced mu opioid receptor pre- and post- synaptic action in the spinal cord. Pain. 2005;117:77–87.
Benedetti F, Vighetti S, Amanzio M, et al. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain. 1998;74:205–11.
Przewłocki R, Przewłocka B. Opioids in chronic pain. Eur J Pharmacol. 2001;429:79–91.
Sikandar S, Dickenson AH. Visceral pain: the ins and outs, the ups and downs. Curr Opin Support Palliat Care. 2012;6:17–26.
Mika J, Zychowska M, Popiolek-Barczyk K, et al. Importance of glial activation in neuropathic pain. Eur J Pharmacol. 2013;716:106–19.
Gosselin RD, Suter MR, Ru-Rong Ji RR, et al. Glial cells and chronic pain. Neuroscientist. 2010;16:519–31.
Wang S, Lim G, Zeng Q, et al. Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci. 2005;25:488–95.
Gao YJ, Ji RR. Targeting astrocyte signaling for chronic pain. Neurotherapeutics. 2010;7:482–93.
Landry RP, Jacobs VL, Romero-Sandoval EA, et al. Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages. Exp Neurol. 2012;234:340–50.
Cohen SP, Liao W, Gupta A, et al. Ketamine in pain management. Adv Psychosom Med. 2011;30:129–61.
Okon T. Ketamine: an introduction for the pain and palliative medicine physician. Pain Physician. 2007;10:493–500.
Vorobeychik Y, Willoughby CD, Mao J. NMDA receptor antagonists in the treatment of pain. In: Deer R, Leong MS, Buvanendran A, et al., editors. Comprehensive treatment of chronic pain by medical, interventional, and integrative approaches. New York: Springer; 2013. p. 61–7.
Apkarian AV, Bushnell MC, Treede RD, et al. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463–84.
Carlson JD, Maire JJ, Martenson ME, et al. Sensitization of pain-modulating neurons in the rostral ventromedial medulla after peripheral nerve injury. J Neurosci. 2007;27:13222–31.
Fields HL. Pain modulation, expectation, opioid analgesia and virtual pain. Prog Brain Res. 2000;122:245–53.
Zhou M. Glutamate receptors and persistent pain: targeting forebrain NR2B subunits. Drug Discov Today. 2002;8:259–67.
Cohen SP, Raja SN. Pain. In: Goldman L, Schafer AI, editors. Cecil textbook of medicine. 24th ed. Philadelphia: Saunders; 2011. p. 133–9.
Zhou M, Gebhart GF. Biphasic modulation of spinal nociceptive transmission from the medullary raphe nuclei in the rat. J Neurophysiol. 1997;78:746–58.
Goffaux P, Redmond WJ, Rainville P, et al. Descending analgesia - when the spine echoes what the brain expects. Pain. 2007;130:137–43.
Enck P, Benedetti F, Schedlowski M. New insights into the placebo and once I responses. Neuron. 2008;59:195–206.
Grachev I, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain. 2000;89:7–18.
Iadarola MJ, Max MB, Berman KF, et al. Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain. 1995;63:55–64.
Apkarian AV, Baliki MN, Geha PY. Towards a theory of chronic pain. Prog Neurobiol. 2009;87:81–97.
Rouwette T, Vanelderen P, Roubos EW, et al. The amygdala, a relay station for switching on and off pain. Eur J Pain. 2012;16:782–92.
Seminowicz DA, Wideman TH, Naso L, et al. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J Neurosci. 2011;31:7540–50.
Apkarian AV, Sosa Y, Krauss BR, et al. Chronic pain patients are impaired on an emotional decision-making task. Pain. 2004;108:129–36.
Dick BD, Rashiq S. Disruption of attention and working memory traces in individuals with chronic pain. Anesth Analg. 2007;104:1223–9.
Sjogren P, Christrup LL, Petersen MA, et al. Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain center. Eur J Pain. 2005;9:453–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Christiansen, S., Cohen, S.P. (2018). Chronic Pain: Pathophysiology and Mechanisms. In: Manchikanti, L., Kaye, A., Falco, F., Hirsch, J. (eds) Essentials of Interventional Techniques in Managing Chronic Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-60361-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-60361-2_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60359-9
Online ISBN: 978-3-319-60361-2
eBook Packages: MedicineMedicine (R0)